Dare Bioscience notified of Nasdaq delisting risk over equity deficiency
Dare Bioscience was notified by Nasdaq's Listing Qualifications Staff on July 13, 2026, that the company no longer complies with Nasdaq Listing Rule 5550(b)…
$2.5Mequity$35M
Company
SEC filing news and material events for Dare Bioscience, Inc., briefed from primary-source filings.
1 story
Dare Bioscience was notified by Nasdaq's Listing Qualifications Staff on July 13, 2026, that the company no longer complies with Nasdaq Listing Rule 5550(b)…